Effective 16 October 2026, PT Anugerah Pharmindo Lestari (APL), a Zuellig Pharma company, has been officially appointed by Ego Pharmaceuticals to manage QV® in Indonesia. Under this partnership, APL will oversee marketing authorization, nationwide distribution, and end-to-end commercial activities to drive the brand’s presence across the country.
This strategic move reinforces APL’s strategic priority to strengthen and scale its Consumer Healthcare portfolio in Indonesia. By integrating QV® into its portfolio, the partnership aims to significantly expand the brand’s reach across hospital networks, independent pharmacies, modern retail chains, and e-commerce platforms.
First formulated in Australia through close collaboration with dermatologists, QV® has established strong brand equity worldwide as a skincare line specifically formulated for dry and sensitive skin conditions. This brand has deep trust among healthcare professionals, dermatologists, and consumers globally.
Through this collaboration, APL looks forward to expanding QV®’s reach in Indonesia, making trusted skincare more accessible to consumers. This also marks an exciting new chapter for QV® in Indonesia. APL remains committed to bringing trusted skincare solutions closer to more Indonesian families.